Int J Surg. 2024 Jul 22. doi: 10.1097/JS9.0000000000001981. Online ahead of print.
ABSTRACT
The management and outcomes of patients with thymoma associated with myasthenia gravis (TAMG) are heterogeneous. Here, we propose a novel classification system based on Masaoka stage and Myasthenia Gravis Foundation of America (MGFA) classification, aiming to guide surgical decisions and perioperative management for these patients. Considering both oncological and neurological factors, this novel TAMG classification provides valuable information on outcome stratification and clinical decision-making for TAMG.
PMID:39037728 | DOI:10.1097/JS9.0000000000001981
